The current valuation score of Quoin Pharmaceuticals Ltd is 7.49, ranking 226 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.46, which is -23891.78% below the recent high of 109.97 and -1403443.81% above the recent low of -6487.18.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.